Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout

Pharmacology Biochemistry and Behavior

Volumn 86, Issue 4, 2007, Pages 813-821

  Chu, Kathleen ^a   Koob, George F ^a   Cole, Maury ^a   Zorrilla, Eric P ^a   Roberts, Amanda J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Abstinence; Corticotropin releasing factor; CRF1; Dependence; Ethanol self administration; Mouse

Indexed keywords

ANTALARMIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1;

ALCOHOL BLOOD LEVEL; ALCOHOLISM; ANIMAL EXPERIMENT; APPETITE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; KNOCKOUT GENE; MOTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ALCOHOLISM; ANIMALS; CONDITIONING, OPERANT; ETHANOL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SELF ADMINISTRATION;

MUS;

EID: 34249750003     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.03.009     Document Type: Article

References (40)

1. Adinoff B., Anton R., Linnoila M., Guidotti A., Nemeroff C.B., and Bissette G. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence. Neuropsychopharmacology 15 (1996) 288-295
2. Akiyama M., Kirihara T., Takahashi S., Minami Y., Yoshinobu Y., Moriya T., et al. Modulation of mPer1 gene expression by anxiolytic drugs in mouse cerebellum. Br J Pharmacol 128 (1999) 1616-1622
3. Becker H.C., and Lopez M.F. Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcohol Clin Exp Res 28 (2004) 1829-1838
4. 1-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J Comp Neurol 420 (2000) 305-323
5. Contarino A., Dellu F., Koob G.F., Smith G.W., Lee K.F., Vale W., et al. Reduced anxiety-like and cognitive performance in mice lacking the corticotrpin-releasing factor receptor 1. Brain Res 835 (1999) 1-9
6. De Soto C.B., O'Donnell W.E., and De Soto J.L. Long-term recovery in alcoholics. Alcohol Clin Exp Res 13 (1989) 693-697
7. Ehrenreich H.J., Schuck J., Stender N., Pilz J., Gefeller O., Schilling L., et al. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res 21 (1997) 1285-1293
8. Finn D.A., Snelling C., Fretwell A.M., Tanchuck M.A., Underwood L., Cole M., Crabbe J.C., and Roberts A.J. Expression of withdrawal-induced drinking is blocked by the CRF receptor antagonist d-Phe-CRF(12-41). Alcohol., Clin. Exp. Res. 31 (2007) 1-11
9. Funk C.K., Zorrilla E.P., Lee M.-J., Rice K.C., and Koob G.F. Corticotropin-releasing factor1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry 16 (2007) 78-86
10. Hershon H.I. Alcohol withdrawal symptoms and drinking behavior. J Stud Alcohol 38 (1977) 953-971
11. Kanematsu T., Jang I.-S., Yamaguchi T., Nagahama H., Yoshimura K., Hidaka K., et al. Role of the PLC-related, catalytically inactive protein p130 in GABAA receptor function. EMBO 21 (2002) 1004-1011
12. Kreek M.J., and Koob G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51 (1998) 23-47
13. 1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared Fawn-Hooded rats. Neuroscience 117 (2003) 243-247
14. Lopez M.F., and Becker H.C. Effect of pattern and number of chronic ethanol exposures on subsequent voluntary ethanol intake in C57BL/6J mice. Psychopharmacology 181 (2005) 688-696
15. Miller W.R., and Harris R.J. A simple scale of Gorski's warning signs for relapse. J Stud Alcohol 61 (2000) 759-765
16. Mossberg D., Liljeberg P., and Borg S. Clinical conditions in alcoholics during long-term abstinence: a descriptive, longitudinal treatment study. Alcohol 2 (1985) 551-553
17. 1 receptors. Science 303 (2004) 1512-1514
18. O'Connor J.C., Davis L.G., Frame S.R., and Cook J.C. Evaluation of a tier 1 screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486. Toxicol Sci 54 (2000) 338-354
19. O'Dell L.E., Roberts A.J., Smith R.T., and Koob G.F. Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol Clin Exp Res 28 (2004) 1676-1682
20. Olive M.F., Koenig H.N., Nannini M.A., and Hodge C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav 72 (2002) 213-220
21. 1 receptors. Pharmacol Biochem Behav 77 (2004) 405-413
22. Overstreet D.H., Knapp D.J., and Breese G.R. Pharmacological modulation of repeated ethanol withdrawal-induced anxiety-like behavior differs in alcohol-preferring P and Sprague-Dawley rats. Pharmacol Biochem Behav 81 (2005) 122-130
23. Pandey S.C., Roy A., and Zhang H. The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats. Alcohol Clin Exp Res 27 (2004) 396-409
24. Parsons O.A., Schaeffer K.W., and Glenn S.W. Does neuropsychological test performance predict resumption of drinking in posttreatment alcoholics?. Addict Behav 15 (1990) 297-307
25. Pich E.M., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., and Koob G.F. Weiss increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15 (1995) 5439-5447
26. Rassnick S., Heinrichs S.C., Britton K.T., and Koob G.F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605 (1993) 25-32
27. Rassnick S., Koob G.F., and Geyer M.A. Responding to acoustic startle during chronic ethanol intoxication and withdrawal. Psychopharmacology 106 (1992) 351-358
28. Rimondini R., Sommer W., and Heilig M. A temporal threshold for induction of persistent alcohol preference: behavioral evidence in a rat model of intermittent intoxication. J Stud Alcohol 64 (2003) 445-449
29. Roberto M., Madamba S.G., Stouffer D.G., Parsons L.H., and Siggins G.R. Increased GABA release in the central amygdala of ethanol-dependent rats. J Neurosci 24 (2004) 10159-10166
30. Roberts A.J., Cole M., and Koob G.F. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin Exp Res. 20 (1996) 1289-1298
31. Roberts A.J., Heyser C.J., Cole M., Griffin P., and Koob G.F. Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22 (2000) 581-594
32. Roberts A.J., McDonald J.S., Heyser C.J., Kieffer B.L., Matthes H.W.D., Koob G.F., et al. Mu opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther 293 (2000) 1002-1008
33. 1 receptors. Science 296 (2002) 931-933
34. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20 (1998) 1093-1102
35. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., et al. Impaired stress response to reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet. 19 (1998) 162-166
36. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., et al. Increased ethanol self-administration and anxiety-like behavior during acute withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res 26 (2002) 1494-1501
37. Valdez G.R., Zorrilla E.P., Roberts A.J., and Koob G.F. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol 29 (2003) 55-60
38. Van Pett K., Viau V., Bittencourt J.C., Chan R.K.W., Li H.Y., Arias C., et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428 (2000) 191-212
39. Wilkins J.N., Gorelick D.A., Nademanee K., Taylor A., and Herzberg D.S. Hypothalamic-pituitary function during alcohol exposure and withdrawal and cocaine exposure. Recent Dev Alcohol 10 (1992) 57-71
40. Zorrilla E.P., and Koob G.F. The therapeutic potential of CRF1 antagonists for anxiety. Expert Opin Investig Drugs 13 (2004) 799-828